Building Oversight That Outlasts You

Part of Principal Investigator (PI) Training: Inspection, Findings and the Record.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Everything in this course has described what one investigator does. A research site that depends on one person paying attention is fragile: it degrades when you are on leave, and it ends when you move.

The last thing worth learning is how to make the oversight structural — so that a good site keeps being a good site through a staff change, a bad quarter, and your eventual successor.

Closing a trial properly

Reports. Section 2.13 requires the investigator, on completion of the trial, to provide the required reports — with a summary of the trial and its outcome going to the institution, the IRB/IEC and the regulatory authorities as applicable. Diarize it. Final reports to ethics committees are among the most commonly forgotten obligations in clinical research, because by then everyone has moved on.

Participants. Section 2.9.3 provides for informing participants of the results and, as applicable, the treatment they received, when available and according to their preference. Ask at consent how they want to be told, and honor it — including for people who withdrew early.

Records. Sections 2.12.11 to 2.12.13: maintain the essential records described in Appendix C, retain them per applicable regulatory requirements or until the sponsor indicates otherwise — whichever is longer — and give the sponsor the name of the person responsible for maintaining them during the retention period.

Note the two traps. E6(R3) states no retention period in years; the numbers you have heard come from regional regulation, and "whichever is longest" governs. And the named responsible person must be someone who will still be reachable — which usually means an institutional role rather than an individual who may change jobs.

The five artifacts that make a site durable

None of these is required by name. Together they are what separates a site that is good because of one person from a site that is good because of how it works.

  1. A site-level standard operating procedure set. Short and real: consent, eligibility review, event assessment and reporting, product handling, delegation and training, data review, deviation handling. Two pages each, written by the people who do the work.
  2. An onboarding pack for new staff and new investigators. So that a new fellow reaches competence in a week rather than by absorption over six months.
  3. A training matrix. Role by requirement, with dates and renewal points, reconciled against the delegation log.
  4. A single site calendar. Every recurring obligation with an owner: CV and license refresh, the weekly medical review, quarterly self-audit, annual ethics reports, retention checkpoints.
  5. A finding-and-fix log. Everything found by anyone — you, a monitor, an auditor, an inspector — with the cause, the fix, the owner and the verification date. This is the site's institutional memory, and it is the document a successor most needs.

Succession

Investigators change. Plan for it before it is urgent.

An investigator who leaves cleanly protects both the participants and the trial. One who leaves abruptly creates a gap in oversight that shows up in the data for months.

The last thing

Everything in this course reduces to a single question you can ask yourself in a quiet moment about any participant in any trial you run:

If a regulator asked me tomorrow how I know that this person was properly consented, properly eligible, properly cared for, and that the data reported about them is true — could I show them?

If the answer is yes, the systems are working. If it is no, you have found the next thing to fix. That question, asked regularly, is what investigator oversight actually is.

Key takeaways